DuPont raises annual profit forecasts on strong healthcare, aerospace demand

DuPont has raised its full-year profit forecasts and projected fourth-quarter earnings exceed analyst estimates. The company experienced strong demand in healthcare, aerospace, and industrial water markets during the third quarter. DuPont's healthcare and water technologies segment reported nearly 4% growth year-over-year, reaching $865 million in net sales. Additionally, the company recently concluded a $250 million share repurchase program and plans to buy back an additional $250 million of shares.

DuPont raised its full-year profit forecasts on Tuesday and projected fourth-quarter earnings above Wall Street estimates as strong demand in its healthcare, aerospace and industrial water markets fueled a third-quarter earnings beat.

The industrial materials maker has been streamlining its portfolio and focusing on higher-growth end markets such as semiconductors, healthcare, water technologies and aerospace, while returning cash to shareholders through share repurchases and divestitures.

As on 03 Nov 2026, 02:30 AM IST

S&P 500 Top Gainers

IDEXX Laboratories671.64(21.85%)

Molson Coors Beverage43.23(7.75%)

LKQ19.93(7.38%)

Howmet Aerospace212.99(6.91%)

Gainers"

S&P 500 Top Losers

Intel59.97(-8.80%)

Oracle119.22(-8.76%)

Coterra Energy32.56(-8.62%)

Datadog216.10(-8.15%)

Losers"

For live updates on US Markets, click here

It spun off its electronics business, which includes semiconductor technologies and interconnect solutions, into independent public company Qnity Electronics last year.

DuPont had also increased prices to offset higher feedstock and energy costs, improved productivity and reduced debt to support earnings at a time when the global chemicals industry was grappling with weak demand in key end markets.

The company raised its 2026 adjusted core profit outlook to nearly $1.79 billion, from its previous forecast range of $1.75 billion-$1.77 billion.

It now expects annual adjusted earnings of $7.47-$7.52 per share, compared with $7.17-$7.32 per share previously.

CFO Antonella Franzen said DuPont expected full-year results to come in at or above the high end of its prior guidance.

It concluded a $250 million accelerated share repurchase program and substantially completed $100 million of open-market share repurchases during the third quarter, DuPont said.

The company plans to repurchase an additional $250 million of shares in the fourth quarter.

Net sales at its healthcare and water technologies segment rose nearly 4% to $865 million from a year earlier, while sales at its diversified industrials segment increased 4.2% to more than $1 billion.

The company forecast current-quarter adjusted earnings of $1.90-$1.95 per share, above analysts' average estimate of $1.87 apiece, according to data compiled by LSEG.

Wilmington, Delaware-based DuPont reported adjusted profit of $2.09 per share for the three months ended September 30, topping analysts' estimate of $1.87 per share.